0001437749-19-015089.txt : 20190830 0001437749-19-015089.hdr.sgml : 20190830 20190801060308 ACCESSION NUMBER: 0001437749-19-015089 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 CORRESP 1 filename1.htm bcda20190731b_corresp.htm

 

July 31, 2019

 

Securities and Exchange Commission

100 F. Street, NE

Washington, D.C. 20549

 

 

Re:

BioCardia, Inc.
 

 

Registration Statement on Form S-1
 

 

File No. 333-230779

 

VIA EDGAR

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:30 p.m., Washington D.C. time, on Thursday, August 1, 2019, or as soon thereafter as practicable.

 

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

 

(i)

Date of preliminary prospectus: July 23, 2019.

(ii)

Dates of distribution: July 23, 2019 through the date hereof.

(iii)

Number of prospective underwriters and selected dealers to whom the preliminary prospectus was furnished: 12.

(iv)

Number of prospectuses so distributed: 540.

 

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

 

 

[Signature Page Follows]

 

 
 

 

 

MAXIM GROUP LLC

 

 

By:  /s/ Clifford A. Teller                           

Name: Clifford A. Teller

Title: Executive Managing Director

Head of Investment Banking